trivago Deepens Partnership With Ai-Driven Tech Platform Holisto
July 30, 2024 17:41 ET
|
trivago N.V.
Strategic Investment Allows for an Enhanced End-User Experience and added value for its advertisers July 30, 2024 – Düsseldorf, Germany – trivago, a leading global hotel search platform, is...
Remuneration of Directors by distribution of Millicom (Tigo) shares
July 30, 2024 17:30 ET
|
Millicom International Cellular S.A.
Remuneration of Directors by distribution of Millicom (Tigo) shares Luxembourg, July 30, 2024 – Millicom International Cellular S.A. ("Millicom") announces that, in accordance with the resolution of...
DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
July 30, 2024 17:30 ET
|
DBV Technologies S.A.
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345...
DBV Technologies publie son Rapport Financier Semestriel 2024 ― Modalités de mise à disposition ou de consultation
July 30, 2024 17:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 30 juillet 2024 DBV Technologies publie son Rapport Financier Semestriel 2024 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN :...
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 30, 2024 17:30 ET
|
Eton Pharmaceuticals
DEER PARK, Ill., July 30, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (“Eton” or the "Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing...
Gaming and Leisure Properties Announces Pricing of $800,000,000 of 5.625% Senior Notes Due 2034 and $400,000,000 of 6.250% Senior Notes Due 2054
July 30, 2024 17:16 ET
|
Gaming and Leisure Properties, Inc.
WYOMISSING, Pa,, July 30, 2024 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (“GLPI”) (NASDAQ: GLPI) today announced the pricing of a public offering of $1,200,000,000 aggregate principal...
New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI® (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer’s Disease Patients Presented at The Alzheimer’s Association International Conference (AAIC) 2024
July 30, 2024 17:15 ET
|
Biogen Inc.
51% of No Tau / Low Tau Patients Showed Improved Cognition and Function Over Three Years; Only Lecanemab Has Clinical Data in No Tau / Low Tau Patient Group Clinical Data and Biomarkers Show...
Singular Genomics to Report Second Quarter 2024 Financial Results on August 13, 2024
July 30, 2024 17:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to...
Geismar 3 (“G3”) Produces First Methanol and Methanex Reports Higher Second Quarter 2024 Earnings
July 30, 2024 17:03 ET
|
Methanex Corporation
Except where otherwise noted, all currency amounts are stated in United States dollars. Net income attributable to Methanex shareholders of $35 million and Adjusted EBITDA of $164 million in the...
Urgently Announces Second Quarter 2024 Earnings Release Date and Conference Call; Participation in Sidoti Virtual Investor Conference
July 30, 2024 17:00 ET
|
Urgent.ly Inc.
VIENNA, Va., July 30, 2024 (GLOBE NEWSWIRE) -- Urgent.ly, Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today...